NACDS is soliciting members’ comments this week on the implementation of the Bureau of Narcotics and Dangerous Drugs Control’s recent announcement regarding changes to the prescription drug monitoring program (PDMP) reporting requirements. As a result of the enactment of Oklahoma SB 848, prescribers are required to document any opioid prescription as being acute or chronic on the face of the prescription. As a result, the PDMP is looking to utilize this data by requiring pharmacies to report any opioid as being used for the treatment of acute or chronic pain. Along with this requirement, the PDMP is also requiring pharmacies to report a value of “99-Other” for any non-opioid controlled substance prescription.
NACDS’ analysis of this change is that most pharmacies will need to implement a block in their prescription fulfillment systems to ensure treatment type codes are being entered and reported accordingly for all opioid prescriptions in accordance with SB 848. This is creating a concern in that requiring a value of “99-Other” for all non-opioid controlled substances will create workflow issues in pharmacies which will cause a negative impact for patients.
For more information, contact NACDS’ Mary Staples at 817-442-1155.